HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Noriaki Tsubota Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okada, M. Articles by Miyamoto, Y. Search for Related Content PubMed PubMed Citation Articles by Okada, M. Articles by Miyamoto, Y.

J Thorac Cardiovasc Surg 1998;115:836-840
© 1998 Mosby, Inc.

GENERAL THORACIC SURGERY

Operative approach for multiple primary lung carcinomas

From the Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan.

Received for publication May 21, 1997. Revisions requested July 22, 1997; revisions received Nov. 17, 1997. Accepted for publication Dec. 9, 1997. Address for reprints: N. Tsubota, MD, Department of Thoracic Surgery, Hyogo Medical Center for Adults, Kitaohji-cho 13-70, Akashi City 673, Hyogo, Japan.

Of 908 patients who underwent operation for primary lung cancer between January 1985 and June 1996, we considered 57 (6.3%) to have a second primary lung cancer, which was synchronous in 28 cases (3.1%) and metachronous in 29 cases (3.2%). Five-year survival for patients with synchronous and metachronous disease from initial treatment of cancer was 70.3% and 66.0%, respectively. Survival after the development of a metachronous lesion was 32.9% at 5 years. Sixteen of the synchronous second tumors (57%) were detected on preoperative radiography or bronchoscopy and 11 (39%) at the time of operation. Survival of patients at stage I or II from treatment of a synchronous lesion (p = 0.002) and of a metachronous second lesion (p = 0.028) was significantly better compared with those at stage III or IV. Therefore it is important to carefully examine a synchronous lesion before and during the operation of a primary lung cancer and to perform close follow-up surveillance for early detection of a metachronous lesion. In treating multiple lung carcinomas consideration should always be given to performing precise staging, aggressive operative approach for early stage, and oncologically sound parenchymal sparing procedures.

This article has been cited by other articles:

				B. E. Lee, J. L. Port, B. M. Stiles, J. Saunders, S. Paul, P. C. Lee, and N. Altorki TNM Stage Is the Most Important Determinant of Survival in Metachronous Lung Cancer. Ann. Thorac. Surg., October 1, 2009; 88(4): 1100 - 1105. [Abstract] [Full Text] [PDF]

				X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al. Evidence for Common Clonal Origin of Multifocal Lung Cancers J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570. [Abstract] [Full Text] [PDF]

				M. Riquet, A. Cazes, K. Pfeuty, U. D. Ngabou, C. Foucault, A. Dujon, and E. Banu Multiple Lung Cancers Prognosis: What About Histology? Ann. Thorac. Surg., September 1, 2008; 86(3): 921 - 926. [Abstract] [Full Text] [PDF]

				K. R. Shen, B. F. Meyers, J. M. Larner, and D. R. Jones Special Treatment Issues in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 290S - 305S. [Abstract] [Full Text] [PDF]

				M. Mun and T. Kohno Single-Stage Surgical Treatment of Synchronous Bilateral Multiple Lung Cancers Ann. Thorac. Surg., March 1, 2007; 83(3): 1146 - 1151. [Abstract] [Full Text] [PDF]

				K. Kushibe, T. Kawaguchi, Y. Nishimoto, M. Takahama, T. Tojo, and S. Taniguchi Operative indications for lung cancer with satellite lesions. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 316 - 320. [Abstract] [Full Text] [PDF]

				M. Okada, T. Sakamoto, T. Yuki, T. Mimura, K. Miyoshi, and N. Tsubota Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., March 1, 2006; 81(3): 1028 - 1032. [Abstract] [Full Text] [PDF]

				M. J. Flynn, D. Rassl, A. El Shahira, B. Higgins, and S. Barnard Metachronous and Synchronous Lung Tumors: Five Malignant Lung Pathologies in 1 Patient During 7 Years Ann. Thorac. Surg., December 1, 2004; 78(6): 2154 - 2155. [Abstract] [Full Text] [PDF]

				M. Nakata, S. Sawada, M. Yamashita, H. Saeki, A. Kurita, S. Takashima, and K. Tanemoto Surgical Treatments for Multiple Primary Adenocarcinoma of the Lung Ann. Thorac. Surg., October 1, 2004; 78(4): 1194 - 1199. [Abstract] [Full Text] [PDF]

				M. Okada, W. Nishio, T. Sakamoto, K. Uchino, T. Yuki, A. Nakagawa, and N. Tsubota Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1,465 consecutive patients undergoing complete resection Ann. Thorac. Surg., June 1, 2004; 77(6): 1926 - 1930. [Abstract] [Full Text] [PDF]

				R. J. Battafarano, S. D. Force, B. F. Meyers, J. Bell, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Benefits of resection for metachronous lung cancer J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 836 - 842. [Abstract] [Full Text] [PDF]

				M. Okada, W. Nishio, T. Sakamoto, K. Uchino, and N. Tsubota Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma Ann. Thorac. Surg., December 1, 2003; 76(6): 1828 - 1832. [Abstract] [Full Text] [PDF]

				Y.-W. Tung, C.-P. Hsu, S.-E. Shai, J.-Y. Hsia, S.-S. Yang, and C.-Y. Chen Surgical feasibility of ipsilateral multifocal non-small cell lung cancer in different lobes: excellent survival in node-negative subgroup Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1008 - 1012. [Abstract] [Full Text] [PDF]

				M. Okada, W. Nishio, T. Sakamoto, H. Harada, K. Uchino, and N. Tsubota Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 558 - 562. [Abstract] [Full Text] [PDF]

				R. J. Battafarano, B. F. Meyers, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Surgical resection of multifocal non-Small cell lung cancer is associated with prolonged survival Ann. Thorac. Surg., October 1, 2002; 74(4): 988 - 994. [Abstract] [Full Text] [PDF]

				N. Seki, T. Takasu, K. Mandai, M. Nakata, H. Saeki, Y. Heike, I. Takata, Y. Segawa, T. Hanafusa, and K. Eguchi Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung Clin. Cancer Res., October 1, 2002; 8(10): 3046 - 3053. [Abstract] [Full Text] [PDF]

				F. Rea, A. Zuin, D. Callegaro, L. Bortolotti, G. Guanella, and F. Sartori Surgical results for multiple primary lung cancers Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 489 - 495. [Abstract] [Full Text] [PDF]

				C. Doddoli, P. Thomas, O. Ghez, R. Giudicelli, and P. Fuentes Surgical management of metachronous bronchial carcinoma Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 899 - 903. [Abstract] [Full Text] [PDF]

				M. Okada, K. Yoshikawa, T. Hatta, and N. Tsubota Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann. Thorac. Surg., March 1, 2001; 71(3): 956 - 960. [Abstract] [Full Text] [PDF]

				R. B. Ponn Lightning Can Strike Twice : Second Primary Lung Cancers Chest, December 1, 2000; 118(6): 1526 - 1529. [Full Text] [PDF]

				L. Voltolini, P. Paladini, L. Luzzi, C. Ghiribelli, M. Di Bisceglie, and G. Gotti Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 529 - 534. [Abstract] [Full Text] [PDF]

				M. Th. M. van Rens, P. Zanen, A. Brutel de la Riviere, H. R. J. Elbers, H. A. van Swieten, and J. M. M. van den Bosch Survival in Synchronous vs Single Lung Cancer : Upstaging Better Reflects Prognosis Chest, October 1, 2000; 118(4): 952 - 958. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]

				M. Okada, H. Yamagishi, S. Satake, H. Matsuoka, Y. Miyamoto, M. Yoshimura, and N. Tsubota SURVIVAL RELATED TO LYMPH NODE INVOLVEMENT IN LUNG CANCER AFTER SLEEVE LOBECTOMY COMPARED WITH PNEUMONECTOMY J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 814 - 819. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, H. Matsuoka, S. Satake, and H. Yamagishi EXTENDED SLEEVE LOBECTOMY FOR LUNG CANCER: THE AVOIDANCE OF PNEUMONECTOMY J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 710 - 714. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and R. Nakai Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis Ann. Thorac. Surg., August 1, 1999; 68(2): 326 - 330. [Abstract] [Full Text] [PDF]

				M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL? J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275. [Abstract] [Full Text] [PDF]

				Multiple primary lung carcinomas J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 405 - 405. [Full Text]

				Profound systemic hypothermia and release of neurotransmitter amino acids J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 406 - 406. [Full Text]